The effect of fucoxanthin rich power on the lipid metabolism in rats with a high fat diet
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
This study determined the effects of fucoxanthin on gene expressions related to lipid metabolism in rats with a high-fat diet. Rats were fed with normal fat diet (NF, 7% fat) group, high fat diet group (HF, 20% fat), and high fat with 0.2% fucoxanthin diet group (HF+Fxn) for 4 weeks. Body weight changes and lipid profiles in plasma, liver, and feces were determined. The mRNA expressions of transcriptional factors such as sterol regulatory element binding protein (SREBP)-1c, Carnitine palmitoyltransferase-1 (CPT1), Cholesterol 7α-hydroxylase1 (CYP7A1) as well as mRNA expression of several lipogenic enzymes were determined. Fucoxanthin supplements significantly increased plasma high density lipoprotein (HDL)concentration (P < 0.05). The hepatic total lipids, total cholesterols, and triglycerides were significantly decreased while the fecal excretions of total lipids, cholesterol, and triglycerides were significantly increased in HF+Fxn group (P < 0.05). The mRNA expression of hepatic Acetyl-CoA carboxylase (ACC), Fatty acid synthase (FAS), and Glucose-6-phosphate dehydrogenase (G6PDH) as well as SREBP-1C were significantly lower in HF+Fxn group compared to the HF group (P < 0.05). The hepatic mRNA expression of Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) and Acyl-CoA cholesterol acyltransferase (ACAT) were significantly low while lecithin-cholesterol acyltransferase (LCAT) was significantly high in the HF+Fxn group (P < 0.05). There was significant increase in mRNA expression of CPT1 and CYP7A1 in the HF+Fxn group, compared to the HF group (P < 0.05). In conclusion, consumption of fucoxanthin is thought to be effective in improving lipid and cholesterol metabolism in rats with a high fat diet.
Abstract
This study determined the effects of fucoxanthin on gene expressions related to lipid metabolism in rats with a high-fat diet. Rats were fed with normal fat diet (NF, 7% fat) group, high fat diet group (HF, 20% fat), and high fat with 0.2% fucoxanthin diet group (HF+Fxn) for 4 weeks. Body weight changes and lipid profiles in plasma, liver, and feces were determined. The mRNA expressions of transcriptional factors such as sterol regulatory element binding protein (SREBP)-1c, Carnitine palmitoyltransferase-1 (CPT1), Cholesterol 7α-hydroxylase1 (CYP7A1) as well as mRNA expression of several lipogenic enzymes were determined. Fucoxanthin supplements significantly increased plasma high density lipoprotein (HDL)concentration (P < 0.05). The hepatic total lipids, total cholesterols, and triglycerides were significantly decreased while the fecal excretions of total lipids, cholesterol, and triglycerides were significantly increased in HF+Fxn group (P < 0.05). The mRNA expression of hepatic Acetyl-CoA carboxylase (ACC), Fatty acid synthase (FAS), and Glucose-6-phosphate dehydrogenase (G6PDH) as well as SREBP-1C were significantly lower in HF+Fxn group compared to the HF group (P < 0.05). The hepatic mRNA expression of Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) and Acyl-CoA cholesterol acyltransferase (ACAT) were significantly low while lecithin-cholesterol acyltransferase (LCAT) was significantly high in the HF+Fxn group (P < 0.05). There was significant increase in mRNA expression of CPT1 and CYP7A1 in the HF+Fxn group, compared to the HF group (P < 0.05). In conclusion, consumption of fucoxanthin is thought to be effective in improving lipid and cholesterol metabolism in rats with a high fat diet.
참고문헌 (30)
- Barres R, "DNA methylation in metabolic disorders", Am J Clin Nutr, 93, pp.897S~900S (2011)
- Marchesini G, "Nonalcoholic fatty liver disease and the metabolic syndrome", Curr Opin Lipidol, 16, pp.421~427 (2005)
- Bedogni G, "Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study", Hepatology, 42, pp.44~52 (2005)
- MacArtain P, "Nutritional value of edible seaweeds", Nutr Rev, 65, pp.535~543 (2007)
- Chandini SK, "Seaweeds as a source of nutritionally beneficial compounds - a review", J Food Sci Technol, 45, pp.1~3 (2008)
- Maeda H, "Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues", Biochem Biophys Res Commun, 332, pp.392~397 (2005)
- Miyashita K, "Antiobesity and anti-diabetic effects of allenic carotenoid, fucoxanthin", Agro Food Ind Hi Tech, 21, pp.24~27 (2010)
- Okada T, "Suppressive effect of neoxanthin on the differentiation of 3T3-L1 adipose cells", J Oleo Sci, 57, pp.345~351 (2008)
- Yim MJ, "Suppressive effects of amarouciaxanthin A on 3T3-L1 adipocyte differentiation through down-regulation of PPAR γ and C", EBPα mRNA expression, 2011, pp.59, 1646~1652
- Park HJ, "Beneficial effects of Undaria pinnatifida ethanol extract on diet-inducedinsulin resistance in C57BL", 6J mice, 2011, pp.49, 727~733
- Maeda H, "Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese", diabetic KK-Ay mice, 2007, pp.55, 7701~7706
- Woo MN, "Anti-obese property of fucoxanthin is partly mediated by altering lipid-regulating enzymes and uncoupling proteins of visceral adipose tissue in mice", MOLECULAR NUTRITION & FOOD RESEARCH, 53, pp.1603~1611 (2009), WILEY-V C H VERLAG GMBH
- Jeon SM, "Fucoxanthin-rich seaweed extract suppresses body weight gain and improves lipid metabolism in high-fat-fed C57BL", 6J mice, 2010, pp.5, 961~969
- Maeda H, "Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model", Mol Med Rep, 2, pp.897~902 (2009)
- Hu X, "Combination of fucoxanthin and conjugated linoleic acid attenuates body weight gain and improves lipid metabolism in high-fat dietinduced obese rats", Arch Biochem Biophys, 519, pp.59~65 (2012)
- Woo MN, "Fucoxanthin supplementation improves plasma and hepatic lipid metabolism and blood glucose concentration in high-fat fed C57BL", 6N mice, 2010, pp.186(3), 316~322[DOI]
- Mayes PA, "Biosynthesis of fatty acids, In Harper's Biochemistry", pp.230~257 (2000), Appleton and Lange
- Chen J, "The effects of jiang-zhi-ning and its main components on cholesterol metabolism", Evid Based Complement Alternat Med, 2012, pp.928234~ (2012)
- Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method", Methods, 25, pp.402~408 (2001)
- Frings CS, "A colorimetric method for determination of total serum lipids based on the sulfo-phospho-vanillin reaction", Am J Clin Pathol, 53, pp.89~91 (1970)
- Folch J, "A simple method for the isolation and purification of total lipides from animal tissues", J Biol Chem, 226, pp.497~509 (1957)
- Bettzieche A, "L-cysteine down-regulates SREBP-1c-regulated lipogenic enzymes expression via glutathione in HepG2 cells", Ann Nutr Metab, 52, pp.196~203 (2008)
- Foretz M, "Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes", Proc Natl Acad Sci U S A, 96, pp.12737~12742 (1999)
- Brown MS, "The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor", Cell, 89, pp.331~340 (1997)
- Shimomura I, "Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy", Genes Dev, 12, pp.3182~3194 (1998)
- Diraison F, "Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity", Am J Physiol Endocrinol Metab, 282, pp.E46~E51 (2002)
- Nicolle C, "Effect of carrot intake on cholesterol metabolism and on antioxidant status in cholesterol-fed rat", Eur J Nutr, 42, pp.254~261 (2003)
- Matsumoto M, "Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats", Eur J Nutr, 49, pp.243~249 (2010)
- Siperstein MD, "Regulation of cholesterol biosynthesis in normal and malignant tissues", Curr Top Cell Regul, 2, pp.65~100 (1970)
- Pullinger CR, "Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype", J Clin Invest, 110, pp.109~117 (2002)